The DOI matches its Crossref record; 299 of the 299 references it cites were found in a registry or an index.
Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
Open accessAbstract
Tumor immunotherapy is only effective in a fraction of patients due to a low response rate and severe side effects, and these challenges of immunotherapy in clinics can be addressed through induction of immunogenic cell death (ICD). ICD is elicited from many antitumor therapies to release danger associated molecular patterns (DAMPs) and tumor‐associated antigens to facilitate maturation of dendritic cells (DCs) and infiltration of cytotoxic T lymphocytes (CTLs). The process can reverse the tumor immunosuppressive microenvironment to improve the sensitivity of immunotherapy. Nanostructure‐based drug delivery systems (NDDSs) are explored to induce ICD by incorporating therapeutic molecules for chemotherapy, photosensitizers (PSs) for photodynamic therapy (PDT), photothermal conversion agents for photothermal therapy (PTT), and radiosensitizers for radiotherapy (RT). These NDDSs can release loaded agents at a right dose in the right place at the right time, resulting in greater effectiveness and lower toxicity. Immunotherapeutic agents can also be combined with these NDDSs to achieve the synergic antitumor effect in a multi‐modality therapeutic approach. In this review, NDDSs are harnessed to load multiple agents to induce ICD by chemotherapy, PDT, PTT, and RT in combination of immunotherapy to promote the therapeutic effect and reduce side effects associated with cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–299 of 299
Morisada, M. V., Clavijo, P. E., Moore, E. C., Sun, L., Chamberlin, M. M., Waes, C. V., Hodge, J. W., Mitchell, J. B., Friedman, J., & Allen, C. T. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1395996 · Cited by 152
Liu, X., Feng, Z., Wang, C., Su, Q., Song, H., Zhang, C., Huang, P., Liang, X., Dong, A., Kong, D., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119649 · Cited by 151
Zhou, S., Shang, Q., Wang, N., Li, Q., Song, A., & Luan, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.035 · Cited by 149
Overcoming the obstacles of current photodynamic therapy in tumors using nanoparticles
Lee, D., Kwon, S., Jang, S.-Y., Park, E., Lee, Y., & Koo, H. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.06.019 · Cited by 149
Luo, L., Qi, Y., Zhong, H., Jiang, S., Zhang, H., Cai, H., Wu, Y., Gu, Z., Gong, Q., & Luo, K. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.003 · Cited by 146
Self-citationCathepsin-sensitive nanoscale drug delivery systems for cancer therapy and other diseases
Dheer, D., Nicolas, J., & Shankar, R. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.010 · Cited by 144
Ge, R., Liu, C., Zhang, X., Wang, W., Li, B., Liu, J., Liu, Y., Sun, H., Zhang, D., Hou, Y., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b05876 · Cited by 139
Self-citationIndoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy
Guo, Y., Liu, Y., Wu, W., Ling, D., Zhang, Q., Peng, Z. M., & Hu, X. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121018 · Cited by 138
A transistor-like pH-sensitive nanodetergent for selective cancer therapy
Liu, M., Huang, L., Zhang, W., Wang, X., Geng, Y., Zhang, Y., Wang, L., Zhang, W., Zhang, Y., Xiao, S., et al. (2022) · Nature Nanotechnology · doi:10.1038/s41565-022-01085-5 · Cited by 138
Li, B., Hao, G., Sun, B., Gu, Z., & Xu, Z. P. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909745 · Cited by 137
Self-citationEnzyme-Driven Membrane-Targeted Chimeric Peptide for Enhanced Tumor Photodynamic Immunotherapy
Zhang, C., Gao, F., Wu, W., Qiu, W., Zhang, L., Li, R., Zhuang, Z., Yu, W., Cheng, H. L., & Zhang, X. (2019) · ACS Nano · doi:10.1021/acsnano.9b04315 · Cited by 136
Symphony of nanomaterials and immunotherapy based on the cancer–immunity cycle
Li, Q., Shi, Z., Zhang, F., Zeng, W., Zhu, D., & Mei, L. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.031 · Cited by 136
Wen, Y., Chen, X., Zhu, X., Gong, Y., Yuan, G., Qin, X., & Liu, J. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b17137 · Cited by 134
Recent Advances in Targeted Tumor Chemotherapy Based on Smart Nanomedicines
Qin, S., Zhang, A., & Zhang, X. (2018) · Small · doi:10.1002/smll.201802417 · Cited by 133
Charge-reversal nanocarriers: An emerging paradigm for smart cancer nanomedicine
Zhang, M., Chen, X., Li, C., & Shen, X. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.024 · Cited by 128
Yang, Y., Tang, J., Abbaraju, P. L., Jambhrunkar, M., Song, H., Zhang, M., Lei, C., Fu, J., Gu, Z., Liu, Y., et al. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201807595 · Cited by 126
Self-citationWang, Z., Yu, L., Wang, Y., Wang, C., Mu, Q., Liu, X., Yu, M., Wang, K., Yao, G., & Yu, Z. (2022) · Advanced Science · doi:10.1002/advs.202104793 · Cited by 125
Su, Z., Xiao, Z., Wang, Y., Huang, J., An, Y., Wang, X., & Shuai, X. (2020) · Small · doi:10.1002/smll.201906832 · Cited by 124
Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer
Qiu, X., Qu, Y., Guo, B., Zheng, H., Meng, F., & Zhong, Z. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.002 · Cited by 124
Wang, X., Li, M., Ren, K., Xia, C., Li, J., Yu, Q., Qiu, Y., Lu, Z., Long, Y., Zhang, Z., et al. (2020) · Advanced Materials · doi:10.1002/adma.202002160 · Cited by 122
Nanomedicine-based drug delivery towards tumor biological and immunological microenvironment
Li, J., & Burgess, D. J. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.05.008 · Cited by 121
Bioinspired and biomimetic micro- and nanostructures in biomedicine
Johnson, A. P., Sabu, C., Nivitha, K. P., Sankar, R., Shirin, V. K. A., Henna, T. K., Raphey, V. R., Gangadharappa, H. V., Kotta, S., & Pramod, K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.013 · Cited by 121
Li, L., Li, Y., Yang, C., Radford, D. C., Wang, J., Janat-Amsbury, M.-M., Kopec̆ek, J., & Yang, J. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201908961 · Cited by 119
Tongu, M., Harashima, N., Monma, H., Inao, T., Yamada, T., Kawauchi, H., & Harada, M. (2013) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-012-1343-0 · Cited by 118
Shen, F., Feng, L., Zhu, Y., Tao, D., Xu, J., Peng, R., & Liu, Z. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120190 · Cited by 118
Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy
Zhu, Y., Yu, X., Thamphiwatana, S., Zheng, Y., & Pang, Z. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.08.010 · Cited by 118
Han, M. Y., Huang-Fu, M.-Y., Guo, W.-W., Guo, N., Chen, J., Liu, H.-N., Xie, Z., Lin, M., Wei, Q., & Gao, J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b10098 · Cited by 113
Huang, H., Jiang, C., Shen, S., Liu, A., Gan, Y.-J., Tong, Q., Chen, S.-B., Gao, Z., Du, J., Cao, J., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b01807 · Cited by 112
Lila, A. S. A., Kizuki, S., Doi, Y., Suzuki, T., Ishida, T., & Kiwada, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.02.023 · Cited by 107
Emerging strategies in cancer therapy combining chemotherapy with immunotherapy
Luo, Q., Zhang, L., Luo, C., & Jiang, M. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.017 · Cited by 107
Recent progress in tumor photodynamic immunotherapy
Shen, L., Zhou, T., Fan, Y., Chang, X. Y., Wang, Y., Sun, J., Xing, L., & Jiang, H. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.02.007 · Cited by 107
Hamilton, A. L., Biganzoli, L., Coleman, R. E., Mauriac, L., Hennebert, P., Awada, A. H., Nooij, M., Beex, L. V. A. M., Piccart, M. J., Hoorebeeck, I. V., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf157 · Cited by 105
TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant
Saenz, R., Futalan, D., Leutenez, L., Eekhout, F., Fecteau, J. F., Sundelius, S., Sundqvist, S., Larsson, M., Hayashi, T., Minev, B., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-211 · Cited by 105
Ozturk, M. S., Lee, V. K., Zou, H., Friedel, R. H., Dai, G., & Intes, X. (2020) · Science Advances · doi:10.1126/sciadv.aay7513 · Cited by 105
Remote loading paclitaxel–doxorubicin prodrug into liposomes for cancer combination therapy
Yu, J., Wang, Y., Zhou, S., Li, J., Wang, J., Chi, D., Wang, X., Lin, G., He, Z., & Wang, Y. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.04.011 · Cited by 105
Ji, S., Li, J., Duan, X., Zhang, J., Zhang, Y., Song, M., Li, S., Chen, H., & Ding, D. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202110512 · Cited by 104
Xia, H., Qin, M., Wang, Z., Wang, Y., Chen, B., Wan, F., Tang, M., Pan, X., Yang, Y., Liu, J., et al. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c00185 · Cited by 104
A Checkpoint‐Regulatable Immune Niche Created by Injectable Hydrogel for Tumor Therapy
Li, Q., Zhao, Z., Qin, X., Zhang, M., Du, Q., Li, Z., & Luan, Y. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202104630 · Cited by 102
Self-citationCai, H., Tan, P., Chen, X., Kopytynski, M., Pan, D., Zheng, X., Gu, L., Gong, Q., Tian, X., Gu, Z., et al. (2021) · Advanced Materials · doi:10.1002/adma.202108049 · Cited by 101
Self-citationWang, R., Town, T., Gokarn, V., Flavell, R. A., & Chandawarkar, R. Y. (2006) · Journal of Surgical Research · doi:10.1016/j.jss.2006.06.003 · Cited by 100
Shi, Y. (2020) · Advanced Therapeutics · doi:10.1002/adtp.201900215 · Cited by 100
Chen, S., Li, D., Du, X., He, X., Huang, M., Wang, Y., Yang, X., & Wang, J. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100924 · Cited by 100
Fu, L., Zhang, W., Zhou, X., Fu, J., & He, C. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.01.035 · Cited by 98
Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer
Ramakrishnan, R., & Gabrilovich, D. I. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1390-6 · Cited by 97
A review on core–shell structured unimolecular nanoparticles for biomedical applications
Chen, G., Wang, Y., Xie, R., & Gong, S. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.008 · Cited by 97
Martin, S., Dudek-Perić, A. M., Garg, A. D., Roose, H., Demirsoy, Ş., Eygen, S. V., Mertens, F., Vangheluwe, P., Vankelecom, H. E. J., & Agostinis, P. (2017) · Autophagy · doi:10.1080/15548627.2017.1332550 · Cited by 96
Zhao, H., Chen, H., Guo, Z., Zhang, W., Yu, H., Zhuang, Z., Zhong, H., & Liu, Z. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.124314 · Cited by 95
Wang, Y., Ding, Y., Yao, D., Dong, H., Ji, C., Wu, J., Hu, Y., & Yuan, A. (2021) · Small · doi:10.1002/smll.202006231 · Cited by 93
Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies
Wang, Y., Wang, J., Zhu, D., Wang, Y., Qing, G., Zhang, Y., Liu, X., & Liang, X. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.007 · Cited by 93
Platelet-armored nanoplatform to harmonize janus-faced IFN-γ against tumor recurrence and metastasis
Li, Q., Zhou, Y., He, W., Ren, X., Zhang, M., Jiang, Y., Zhou, Z., & Luan, Y. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.020 · Cited by 93
Magnetic particle targeting for diagnosis and therapy of lung cancers
Saadat, M., Manshadi, M. K. D., Mohammadi, M., Zare, M. J., Zarei, M., Kamali, R., & Sanati‐Nezhad, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.017 · Cited by 92
Aptamer Applications for Targeted Cancer Therapy
Barbas, A. S., Mi, J., Clary, B. M., & White, R. R. (2010) · Future Oncology · doi:10.2217/fon.10.67 · Cited by 88
Wang, Y., Chen, J., Duan, R., Gu, R., Wang, W., Wu, J., Lian, H., Hu, Y., & Yuan, A. (2022) · Advanced Materials · doi:10.1002/adma.202109726 · Cited by 88
Manipulation of immune‒vascular crosstalk: new strategies towards cancer treatment
Zhao, Y., Yu, X., & Li, J. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.09.014 · Cited by 84
Wei, J., Wu, D., Zhao, S., Shao, Y., Xia, Y., Ni, D., Qiu, X., Zhang, J., Chen, J., Meng, F., et al. (2022) · Advanced Science · doi:10.1002/advs.202103689 · Cited by 83
Lin, C., Tong, F., Liu, R., Xie, R., Lei, T., Chen, Y., Yang, Z., Gao, H., & Yu, X. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.10.009 · Cited by 82
Luo, Q., Duan, Z., Li, X., Gu, L., Ren, L. F., Zhu, H., Tian, X., Chen, R., Zhang, H., Gong, Q., et al. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202110408 · Cited by 82
Self-citationXiao, X., Liang, S., Zhao, Y., Pang, M., Ma, P., Cheng, Z., & Lin, J. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121120 · Cited by 81
Weber, J. S., Zarour, H. M., Redman, B. G., Trefzer, U., O'Day, S. J., van den Eertwegh, A. J. M., Marshall, M. E., & Wagner, S. N. (2009) · Cancer · doi:10.1002/cncr.24473 · Cited by 77
Peng, S., Lyford-Pike, S., Akpeng, B., Wu, A. A., Hung, C., Hannaman, D., Saunders, J. R., Wu, T. ‐., & Pai, S. I. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1322-5 · Cited by 77
Li, Y., Zhang, X., Wan, X., Liu, X., Pan, W., Li, N., & Tang, B. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000532 · Cited by 77
Wang, C., Shi, X., Song, H., Zhang, C., Wang, X., Huang, P., Dong, A., Zhang, Y., Kong, D., & Wang, W. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120579 · Cited by 77
Photodynamic therapy with smart nanomedicine
Kim, J., Jo, Y.-U., & Na, K. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01214-5 · Cited by 75
Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39
Michaud, M., Sukkurwala, A. Q., Martins, I., Shen, S., Zitvogel, L., & Kroemer, G. (2012) · OncoImmunology · doi:10.4161/onci.19070 · Cited by 74
PD‐1 Blockade for Improving the Antitumor Efficiency of Polymer–Doxorubicin Nanoprodrug
Gao, F., Zhang, C., Qiu, W., Dong, X., Zheng, D., Wu, W. H., & Zhang, X. (2018) · Small · doi:10.1002/smll.201802403 · Cited by 74
Radiotherapy Complements Immune Checkpoint Blockade
Ngiow, S. F., McArthur, G. A., & Smyth, M. J. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.015 · Cited by 73
Phung, C. D., Nguyen, H. T., Choi, J. Y., Pham, T. T., Acharya, S., Timilshina, M., Chang, J., Kim, J., Jeong, J., Ku, S., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.047 · Cited by 73
Huang, Y., Tong, Z., Sun, S., & Mao, Z. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.024 · Cited by 72
Li, H., Zhang, Y., Shu, H., Lv, W., Su, C., & Nie, F. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121412 · Cited by 68
Duan, Z., Luo, Q., Dai, X., Li, X., Gu, L., Zhu, H., Tian, X., Zhang, H., Gong, Q., Gu, Z., et al. (2021) · Advanced Materials · doi:10.1002/adma.202104594 · Cited by 67
Self-citationHybrid pH-sensitive nanogels surface-functionalized with collagenase for enhanced tumor penetration
Wang, X., Luo, J., He, L., Cheng, X., Yan, G., Wang, J., & Tang, R. (2018) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.04.084 · Cited by 66
Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer
Liu, Y., Qiu, N., Shen, L., Liu, Q., Zhang, J., Cheng, Y., Lee, K., & Huang, L. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.040 · Cited by 65
Designing Hypoxia‐Responsive Nanotheranostic Agents for Tumor Imaging and Therapy
Zhou, H., Qin, F., & Chen, C. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202001277 · Cited by 64
Yang, Y., Hu, D., Lu, Y., Chu, B., He, X., Chen, Y., Xiao, Y., Yang, C., Zhou, K., Yuan, L., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.08.021 · Cited by 64
Yin, Y., Hu, Q., Xu, C., Qiao, Q., Qin, X., Song, Q., Yang, P., Zhao, Y., & Zhang, Z. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00564 · Cited by 62
Immunochemotherapy mediated by thermosponge nanoparticles for synergistic anti-tumor effects
Zhao, Y., Song, Q., Yin, Y., Wu, T., Hu, X., Gao, X., Gao, L., Tan, S., & Zhang, Z. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.037 · Cited by 59
Guan, J., Wu, Y., Liu, X., Wang, H., Ye, N., Li, Z., Xiao, C., Zhang, Z., Li, Z., & Yang, X. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121180 · Cited by 59
Self-citationWei, Y., Gu, X., Cheng, L., Meng, F., Storm, G., & Zhong, Z. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.05.034 · Cited by 56
A bifunctional nanomodulator for boosting CpG-mediated cancer immunotherapy
Wang, Z., Zhang, Y., Liu, Z., Dong, K., Liu, C., Ran, X., Pu, F., Ju, E., Ren, J., & Qu, X. (2017) · Nanoscale · doi:10.1039/c7nr04396a · Cited by 53
Wang, N., Zhou, Y., Xu, Y., Ren, X., Zhou, S., Shang, Q., Jiang, Y., & Luan, Y. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.125995 · Cited by 53
Enhanced Tumor Retention Effect by Click Chemistry for Improved Cancer Immunochemotherapy
Mei, L., Liu, Y., Rao, J., Tang, X., Li, M., Zhang, Z., & He, Q. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b02954 · Cited by 48
Cascade Catalytic Nanoplatform Based on “Butterfly Effect” for Enhanced Immunotherapy
Shao, Y., Wang, Z., Hao, Y., Zhang, X., Wang, N., Chen, K., Chang, J., Feng, Q., & Zhang, Z. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002171 · Cited by 48
The role of radiotherapy in the age of immunotherapy
Sato, H., Demaria, S., & Ohno, T. (2020) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyaa268 · Cited by 48
Zheng, X., Pan, D., Chen, X., Wu, L., Chen, M., Wang, W., Zhang, H., Gong, Q., Gu, Z., & Luo, K. (2021) · Advanced Science · doi:10.1002/advs.202102741 · Cited by 46
Self-citationFang, L., Zhao, Z., Wang, J., Xiao, P., Sun, X., Ding, Y., Zhang, P., Wang, D., & Li, Y. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.006 · Cited by 45
A Redox‐Responsive Nanovaccine Combined with A2A Receptor Antagonist for Cancer Immunotherapy
Yan, P., Luo, Y., Li, X., Li, Y., Wang, Y., Wu, J., & Zhou, S. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101222 · Cited by 45
Mitoxantrone as a prospective photosensitizer for photodynamic therapy of breast cancer
Montazerabadi, A., Sazgarnia, A., Bahreyni-Toosi, M. H., Ahmadi, A., Shakeri‐Zadeh, A., & Aledavood, A. (2011) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2011.08.004 · Cited by 43
Folate-conjugated polyspermine for lung cancer–targeted gene therapy
Zhang, M., Kim, Y.-K., Cui, P., Zhang, J., Qiao, J.-B., He, Y., Lyu, J.-Y., Luo, C.-Q., Xing, L., & Jiang, H. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.03.010 · Cited by 43
Biomimetic erythrocytes engineered drug delivery for cancer therapy
Zhang, W., Zhao, M., Gao, Y., Xu, C., Liu, X., Tang, S., Peng, Y., Wang, N., Hu, D., Peng, H., et al. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.133498 · Cited by 42
Therapeutic Vaccines for Cancer Immunotherapy
Wang, J., Mamuti, M., & Wang, H. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01201 · Cited by 36
Point-source burst of coordination polymer nanoparticles for tri-modality cancer therapy
Ling, X., Han, W., Jiang, X., Chen, X., Rodriguez, M., Zhu, P., Wu, T., & Lin, W. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120690 · Cited by 32
Transformable vesicles for cancer immunotherapy
Wang, S., Hu, X., Wei, W., & Ma, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113905 · Cited by 32
Nanomedicines modulating myeloid-derived suppressor cells for improving cancer immunotherapy
Dai, X., Ren, L. F., Liu, M., Cai, H., Zhang, H., Gong, Q., Gu, Z., & Luo, K. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101163 · Cited by 30
Self-citationZhong, P., Qiu, M., Zhang, J., Sun, H., Cheng, R., Deng, C., Meng, F., & Zhong, Z. (2017) · Nanotechnology · doi:10.1088/1361-6528/aa76cc · Cited by 27
Pan, D., Zheng, X., Zhang, L., Li, X., Zhu, G., Gong, M., Kopytynski, M., Zhou, L., Yi, Y., Zhu, H., et al. (2022) · Advanced Materials · doi:10.1002/adma.202109036 · Cited by 25
Self-citationMulthoff, G. (2009) · International Journal of Hyperthermia · doi:10.1080/02656730902835672 · Cited by 21
Walters, A. A., Wang, J. T.-W., & Al‐Jamal, K. T. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.029 · Cited by 13
Abstract 3753: Indoximod modulates AhR-driven transcription of genes that control immune function
Brincks, E. L., Adams, J., Essmann, M., et al. (2018) · Cancer Research · doi:10.1158/1538-7445.am2018-3753 · Cited by 9
Huang, H., Geng, J., Golzarian, J., Huang, J. T., & Yu, J. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.06.032 · Cited by 7
Cited by
Chiang, M.-R., Hsu, C.-W., Pan, W.-C., Tran, N.-T., Lee, Y.-S., Chiang, W.-H., Liu, Y.-C., Chen, Y.-W., Chiou, S.-H., & Hu, S.-H. (2025) · ACS Nano · doi:10.1021/acsnano.4c09525 · Cited by 174
Gong, J., Cheng, D., Liu, C., Wu, S., Sun, N., Zhao, L., Li, J., Xing, Y., & Zhao, J. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202404184 · Cited by 53
GSH/pH dual response drug delivery system for photothermal enhanced gene-immunotherapy
Ma, T., Li, W., Ye, J., Huang, C., Li, Y., Qiu, H., & Yin, S. (2023) · Nanoscale · doi:10.1039/d3nr03881e · Cited by 21
Wang, D., Lin, S., Li, T., Yang, X., Zhong, X., Chen, Q., Jiang, G., & Li, C. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101275 · Cited by 18
Metadata
- Authors
- Li, Z., Lai, X., Fu, S., Ren, L., Cai, H., Zhang, H., Gu, Z., Ma, X., & Luo, K.
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2022-06-02
- Volume
- 9
- Issue
- 22
- Pages
- e2201734-e2201734
- ISSN
- 2198-3844 (ISSN-L)
- OpenAlex
- W4281678632
- Cited by
- 680
- References
- 299
- FWCI
- 38.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.